BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28388948)

  • 1. Investigating the potential of the anti-epileptic drug imepitoin as a treatment for co-morbid anxiety in dogs with idiopathic epilepsy.
    Packer RM; De Risio L; Volk HA
    BMC Vet Res; 2017 Apr; 13(1):90. PubMed ID: 28388948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of imepitoin (Pexion™) on fear and anxiety related problems in dogs - a case series.
    McPeake KJ; Mills DS
    BMC Vet Res; 2017 Jun; 13(1):173. PubMed ID: 28610629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imepitoin withdrawal in dogs with idiopathic epilepsy well-controlled with imepitoin and phenobarbital and/or potassium bromide does not increase seizure frequency.
    Stee K; Martlé V; Broeckx BJG; Royaux E; Van Ham L; Bhatti SFM
    Vet J; 2017 Dec; 230():1-5. PubMed ID: 29208209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epileptic seizure frequency and semiology in dogs with idiopathic epilepsy after initiation of imepitoin or phenobarbital monotherapy.
    Stabile F; van Dijk J; Barnett CR; De Risio L
    Vet J; 2019 Jul; 249():53-57. PubMed ID: 31239165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of imepitoin for the control of anxiety and fear associated with noise phobia in dogs.
    Engel O; Müller HW; Klee R; Francke B; Mills DS
    J Vet Intern Med; 2019 Nov; 33(6):2675-2684. PubMed ID: 31568622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy.
    Neßler J; Rundfeldt C; Löscher W; Kostic D; Keefe T; Tipold A
    BMC Vet Res; 2017 Jan; 13(1):33. PubMed ID: 28118828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel antiepileptic drug imepitoin compares favourably to other GABA-mimetic drugs in a seizure threshold model in mice and dogs.
    Löscher W; Hoffmann K; Twele F; Potschka H; Töllner K
    Pharmacol Res; 2013 Nov; 77():39-46. PubMed ID: 24056205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up.
    Rundfeldt C; Tipold A; Löscher W
    BMC Vet Res; 2015 Sep; 11():228. PubMed ID: 26330063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin.
    Royaux E; Van Ham L; Broeckx BJ; Van Soens I; Gielen I; Deforce D; Bhatti SF
    Vet J; 2017 Feb; 220():51-54. PubMed ID: 28190495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the effects of first-line antiepileptic drugs on the gait of dogs with idiopathic epilepsy.
    Suiter EJ; Packer RM; Volk HA
    Vet Rec; 2016 Jun; 178(26):652. PubMed ID: 27302918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy.
    Rundfeldt C; Löscher W
    CNS Drugs; 2014 Jan; 28(1):29-43. PubMed ID: 24357084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of imepitoin in the treatment of naive dogs affected by idiopathic epilepsy.
    Gallucci A; Gagliardo T; Menchetti M; Bianchi E; Bucci D; Gandini G
    Vet Rec; 2017 Aug; 181(6):144. PubMed ID: 28600446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs.
    Tipold A; Keefe TJ; Löscher W; Rundfeldt C; de Vries F
    J Vet Pharmacol Ther; 2015 Apr; 38(2):160-8. PubMed ID: 25079881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a ketogenic diet on ADHD-like behavior in dogs with idiopathic epilepsy.
    Packer RM; Law TH; Davies E; Zanghi B; Pan Y; Volk HA
    Epilepsy Behav; 2016 Feb; 55():62-8. PubMed ID: 26773515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the effects of imepitoin on the behaviour of dogs with epilepsy.
    Packer RM; Volk HA
    Vet Rec; 2015 Aug; 177(5):132. PubMed ID: 26231879
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of treatment options for behavioural manifestations of clinical anxiety as a comorbidity in dogs with idiopathic epilepsy.
    Watson F; Rusbridge C; Packer RMA; Casey RA; Heath S; Volk HA
    Vet J; 2018 Aug; 238():1-9. PubMed ID: 30103909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imepitoin is well tolerated in healthy and epileptic cats.
    Engel O; von Klopmann T; Maiolini A; Freundt-Revilla J; Tipold A
    BMC Vet Res; 2017 Jun; 13(1):172. PubMed ID: 28606140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous adverse drug reaction in a dog associated with imepitoin.
    Royaux E; Bhatti S; De Cock H; Van Ham L; Kitshoff A; Vandenabeele S
    Vet Dermatol; 2016 Apr; 27(2):118-21e32. PubMed ID: 26799469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of imepitoin, a recently developed antiepileptic drug, on thyroid parameters and fat metabolism in healthy Beagle dogs.
    Bossens K; Daminet S; Duchateau L; Rick M; Van Ham L; Bhatti S
    Vet J; 2016 Jul; 213():48-52. PubMed ID: 27240915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs.
    Rundfeldt C; Gasparic A; Wlaź P
    J Vet Pharmacol Ther; 2014 Oct; 37(5):421-34. PubMed ID: 24611573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.